SHARE

Austria, Austria

Catapult: 7 start-ups from the DACH region towards the semifinals

23rd June 2022

We are excited to announce the seven start-ups from the DACH region that moves towards the Catapult semifinals!

Meet the start-ups selected from the DACH region to continue their EIT Health Catapult journey! They have been selected from 42 start-ups from across Europe and will advance to the next phase of the programme.

The DACH regional selection ended with the selection of:
⭐ Ablevia biotech GmbH [Austria, BioTech]
⭐ PRAMOMOLECULAR GmbH [Germany, BioTech]
⭐ Freiburger Medizintechnik GmbH [Germany, MedTech]
⭐ Biome Diagnostics [Austria, MedTech]
⭐ XUND [Austria, Digital Health]
⭐ deepeye [Germany, Digital Health]
⭐ edupression.com [Austria, Digital Health]

The 7 projects combine technology and product development in a way that is truly innovative and has the potential to create a better future for European citizens.

 

About

The EIT Health Austria in Vienna is the 8th RIH of EIT Health and started its setup in January 2022. The management board and team can be reached at Austria.Office@eithealth.eu.

EIT Health-supported Vitadio earns permanent DiGA status

EIT Health-supported Vitadio earns permanent DiGA status

Learn how we helped them grow.

Find out more

Skill Sync: Bridging Europe's AI skills gap

Skill Sync: Bridging Europe's AI skills gap

Learn how we're addressing the AI skills gap.

Find out more

EIT Health-supported start-up Ochre Bio signs $1BN+ deal with Boehringer Ingelheim

EIT Health-supported start-up Ochre Bio signs $1BN+ deal with Boehringer Ingelheim

Learn how we supported their journey.

Find out more